Cargando…
Regulatory Affairs 101: Introduction to Expedited Regulatory Pathways
Developing a novel drug, including discovery, nonclinical toxicology studies, initial clinical trials, and thorough pivotal studies, may take many years. Once an applicant has generated this comprehensive body of data, the final step prior to regulatory approval is Health Authority review of the mar...
Autores principales: | Cox, Erica M., Edmund, Anita V., Kratz, Erica, Lockwood, Sarah H., Shankar, Aishwarya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214660/ https://www.ncbi.nlm.nih.gov/pubmed/31909876 http://dx.doi.org/10.1111/cts.12745 |
Ejemplares similares
-
Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications
por: Chiodin, Davy, et al.
Publicado: (2019) -
Data Management 101 for drug developers: A peek behind the curtain
por: Oronsky, Bryan, et al.
Publicado: (2023) -
Regulatory innovation for expansion of indications and pediatric drug development
por: Park, Min Soo
Publicado: (2018) -
Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial
por: Mehrotra, S, et al.
Publicado: (2016) -
An Introduction to Machine Learning
por: Badillo, Solveig, et al.
Publicado: (2020)